التفاصيل البيبلوغرافية
| العنوان: |
SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts. |
| المؤلفون: |
Hoque, M. Nazmul, Sarkar, Md. Murshed Hasan, Rahman, M. Shaminur, Akter, Shahina, Banu, Tanjina Akhtar, Goswami, Barna, Jahan, Iffat, Hossain, M. Saddam, Shamsuzzaman, A. K. Mohammad, Nafisa, Tasnim, Molla, M. Maruf Ahmed, Yeasmin, Mahmuda, Ghosh, Asish Kumar, Osman, Eshrar, Alam, S. K. Saiful, Uzzaman, Mohammad Samir, Habib, Md Ahashan, Mahmud, Abu Sayeed Mohammad, Crandall, Keith A., Islam, Tofazzal |
| المصدر: |
Scientific Reports; 12/15/2021, Vol. 11 Issue 1, p1-17, 17p |
| مصطلحات موضوعية: |
SARS-CoV-2, HUMAN microbiota, COVID-19, COMMUNICABLE diseases, RESPIRATORY diseases, DYSBIOSIS |
| مستخلص: |
The microbiota of the nasopharyngeal tract (NT) play a role in host immunity against respiratory infectious diseases. However, scant information is available on interactions of SARS-CoV-2 with the nasopharyngeal microbiome. This study characterizes the effects of SARS-CoV-2 infection on human nasopharyngeal microbiomes and their relevant metabolic functions. Twenty-two (n = 22) nasopharyngeal swab samples (including COVID-19 patients = 8, recovered humans = 7, and healthy people = 7) were collected, and underwent to RNAseq-based metagenomic investigation. Our RNAseq data mapped to 2281 bacterial species (including 1477, 919 and 676 in healthy, COVID-19 and recovered metagenomes, respectively) indicating a distinct microbiome dysbiosis. The COVID-19 and recovered samples included 67% and 77% opportunistic bacterial species, respectively compared to healthy controls. Notably, 79% commensal bacterial species found in healthy controls were not detected in COVID-19 and recovered people. Similar dysbiosis was also found in viral and archaeal fraction of the nasopharyngeal microbiomes. We also detected several altered metabolic pathways and functional genes in the progression and pathophysiology of COVID-19. The nasopharyngeal microbiome dysbiosis and their genomic features determined by our RNAseq analyses shed light on early interactions of SARS-CoV-2 with the nasopharyngeal resident microbiota that might be helpful for developing microbiome-based diagnostics and therapeutics for this novel pandemic disease. [ABSTRACT FROM AUTHOR] |
|
Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder